MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.370
-0.080 (-5.51%)
Sep 15, 2025, 12:51 PM EDT - Market open

MIRA Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
5.134.716.954.71.470.16
Research & Development
2.743.311.572.350.680.04
Operating Expenses
7.878.028.537.052.150.2
Operating Income
-7.87-8.02-8.53-7.05-2.15-0.2
Interest Expense
---3.46-0.01-0.02-0
Interest & Investment Income
0.110.17----
Pretax Income
-7.77-7.85-11.98-7.06-2.18-0.2
Net Income
-7.77-7.85-11.98-7.06-2.18-0.2
Net Income to Common
-7.77-7.85-11.98-7.06-2.18-0.2
Shares Outstanding (Basic)
1715141813-
Shares Outstanding (Diluted)
1715141813-
Shares Change (YoY)
14.16%10.91%-20.73%38.60%--
EPS (Basic)
-0.46-0.51-0.86-0.40-0.17-
EPS (Diluted)
-0.46-0.51-0.86-0.40-0.17-
EBIT
-7.87-8.02-8.53-7.05-2.15-0.2
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q